Skip to main content

Advertisement

SpringerLink
Log in

Urogenital Autonomic Dysfunction in Diabetes

  • Microvascular Complications—Neuropathy (R Pop-Busui, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

This review details the epidemiology, possible mechanisms, and risk factors associated with urogenital autonomic dysfunction in diabetes. Autonomic neuropathy in diabetes is associated with various urological complications including bladder and sexual dysfunction. Several studies have reported the high prevalence of bladder and sexual dysfunction in both men and women. The DCCT/EDIC UroEDIC study examined the association between cardiovascular autonomic neuropathy and bladder and sexual dysfunction in a large cohort of participants with type 1 diabetes and was the first to report significant associations. Future studies are needed to further evaluate the association of urogenital complications and autonomic dysfunction in diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Wessells H. Insights and interventions in diabetes associated erectile dysfunction. J Urol. 2013;190(1):15–6.

    Article  PubMed  Google Scholar 

  2. ••Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, et al. Urologic complications of diabetes. Diabetes Care. 2005;28(1):177–85. This is an excellent review of the urological complications of diabetes.

    Article  PubMed  Google Scholar 

  3. Jacobson AM, Braffett BH, Cleary PA, Dunn RL, Larkin ME, Wessells H, et al. Relationship of urologic complications with health-related quality of life and perceived value of health in men and women with type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) cohort. Diabetes Care. 2015;38(10):1904–12.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Albers JW, Pop-Busui R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep. 2014;14(8):1–11.

    Article  Google Scholar 

  5. •Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010;33(2):434–41. This study provides a comprehensive clinical overview of cardiovascular autonomic neuropathy in diabetes.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27(7):639–53.

    Article  PubMed  Google Scholar 

  7. Martin CL, Albers JW, Pop-Busui R, Group DER. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):31–8.

    Article  CAS  PubMed  Google Scholar 

  8. Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 2009;119(22):2886–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 2006;29(2):340–4.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Brown JS, Grady DEBO, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstetrics Gynecology. 1999;94(1):66–70.

    CAS  PubMed  Google Scholar 

  11. Sampselle CM, Harlow SD, Skurnick J, Brubaker L, Bondarenko I. Urinary incontinence predictors and life impact in ethnically diverse perimenopausal women. Obstet Gynecol. 2002;100(6):1230–8.

    PubMed  Google Scholar 

  12. Jackson RA, Vittinghoff E, Kanaya AM, Miles TP, Resnick HE, Kritchevsky SB, et al. Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstet Gynecol. 2004;104(2):301–7.

    Article  CAS  PubMed  Google Scholar 

  13. Sarma AVSSJ, Hollingsworth JM, Jacobson DJ, McGree ME, Dunn RL, Lieber MM, et al. Diabetes treatment and progression of benign prostatic hyperplasia in community dwelling black and white men. J Urol. 2012;79(1):102–8.

    Article  Google Scholar 

  14. Joseph MA, Harlow SD, Wei JT, Sarma AV, Dunn RL, Taylor JMG, et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol. 2003;157(10):906–14.

    Article  PubMed  Google Scholar 

  15. Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol. 2000;163(6):1725–9.

    Article  CAS  PubMed  Google Scholar 

  16. Changolkar AK, Hypolite JA, Disanto M, Oates PJ, Wein AJ, Chacko S. Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol. 2005;173(1):309–13.

    Article  CAS  PubMed  Google Scholar 

  17. Hanna-Mitchell AT, Ruiz GW, Daneshgari F, Liu G, Apodaca G, Birder LA. Impact of diabetes mellitus on bladder uroepithelial cells. Am J Physiol Regul Integr Comp Physiol. 2013;304(2):R84–93.

    Article  CAS  PubMed  Google Scholar 

  18. Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S. Diabetic bladder dysfunction: current translational knowledge. J Urol. 2009;182(6 Suppl):S18–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int. 2005;95(6):733–8.

    Article  PubMed  Google Scholar 

  20. Ueda T, Yoshimura N, Yoshida O. Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol. 1997;157(2):580–4.

    Article  CAS  PubMed  Google Scholar 

  21. Bansal R, Agarwal MM, Modi M, Mandal AK, Singh SK. Urodynamic profile of diabetic patients with lower urinary tract symptoms: association of diabetic cystopathy with autonomic and peripheral neuropathy. Urology. 2011;77(3):699–705.

    Article  PubMed  Google Scholar 

  22. Kebapcı N, Yenilmez A, Efe B, Entok E, Demirustu C. Bladder dysfunction in type 2 diabetic patients. Neurourol Urodyn. 2007;26(6):814–9.

    Article  PubMed  Google Scholar 

  23. Pavy-Le Traon A, Fontaine S, Tap G, Guidolin B, Senard JM, Hanaire H. Cardiovascular autonomic neuropathy and other complications in type 1 diabetes. Clin Auton Res. 2010;20(3):153–60.

    Article  PubMed  Google Scholar 

  24. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.

    PubMed  Google Scholar 

  25. Basson R, Berman J, Burnett A, Derogatis L, Ferguson, Fourcroy J, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol. 2000;163(3):888–93.

    Article  CAS  PubMed  Google Scholar 

  26. Enzlin P, Mathieu C, Vanderschueren D, Demyttenaere K. Diabetes mellitus and female sexuality: a review of 25 years’ research. Diabet Med. 1998;15(10):809–15.

    Article  CAS  PubMed  Google Scholar 

  27. Althof SE, Goldstein I, Becher E, Giraldi A, Vardi Y, Dennerstein L, et al. The other side: failure in fair and balanced reporting. J Sex Med. 2005;2(4):583–4.

    Article  PubMed  Google Scholar 

  28. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.

    Article  CAS  PubMed  Google Scholar 

  29. Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care. 2002;25(4):672–7.

    Article  PubMed  Google Scholar 

  30. Enzlin P, Rosen R, Wiegel M, Brown J, Wessells H, Gatcomb P, et al. Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort. Diabetes Care. 2009;32(5):780–5.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537–44.

    Article  CAS  PubMed  Google Scholar 

  32. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993;270(1):83–90.

    Article  Google Scholar 

  33. Fedele D. Therapy insight: sexual and bladder dysfunction associated with diabetes mellitus. Nat Clin Pract Urol. 2005;2(6):282–90.

    Article  PubMed  Google Scholar 

  34. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009;6(5):1232–47.

    Article  PubMed  Google Scholar 

  35. Deutsch S, Sherman L. Previously unrecognized diabetes mellitus in sexually impotent men. JAMA. 1980;244(21):2430–2.

    Article  CAS  PubMed  Google Scholar 

  36. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ, for the Urologic Diseases in America Project. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166(2):207–12.

    Article  PubMed  Google Scholar 

  37. De Berardis G, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH, et al. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care. 2002;25(2):284–91.

    Article  PubMed  Google Scholar 

  38. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54–61.

    CAS  PubMed  Google Scholar 

  39. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science. 1992;257(5068):401–3.

    Article  CAS  PubMed  Google Scholar 

  40. Abu Ali R, Al Hajeri R, Khader Y, Shegem N, Ajlouni K. Sexual dysfunction in Jordanian women. Diabetes Care. 2008;31:1580–1.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kempler P, Amarenco G, Freeman R, Frontoni S, Horowitz M, Stevens M, et al. Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes. Diabetes Metab Res Rev. 2011;27(7):665–77.

    Article  CAS  PubMed  Google Scholar 

  42. Cellek S, Rodrigo J, Lobos E, Fernández P, Serrano J, Moncada S. Selective nitrergic neurodegeneration in diabetes mellitus—a nitric oxide-dependent phenomenon. Br J Pharmacol. 1999;128(8):1804–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Yang CC, Jiang X. Clinical autonomic neurophysiology and the male sexual response: an overview. J Sexual Med. 2009;6 Suppl 3:221–8.

    Article  CAS  Google Scholar 

  44. Fedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Colli E, et al. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care. 1998;21(11):1973–7.

    Article  CAS  PubMed  Google Scholar 

  45. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999;22(1):99–111.

    Article  Google Scholar 

  46. Molitch ME, Steffes MW, Cleary PA, Nathan DM. Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. Kidney Int. 1993;43(3):668–74.

    Article  CAS  PubMed  Google Scholar 

  47. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 2003;348(23):2294–303.

    Article  PubMed  Google Scholar 

  48. Barry MJ, Fowler Jr FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57. discussion 64.

    CAS  PubMed  Google Scholar 

  49. Sandvik H, Hunskaar S, Vanvik A, Bratt H, Seim A, Hermstad R. Diagnostic classification of female urinary incontinence: an epidemiological survey corrected for validity. J Clin Epidemiol. 1995;48(3):339–43.

    Article  CAS  PubMed  Google Scholar 

  50. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–30.

    Article  CAS  PubMed  Google Scholar 

  51. Wessells H, Penson DF, Cleary P, Rutledge BN, Lachin JM, McVary KT, et al. Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J Urol. 2011;185(5):1828–34.

    Article  PubMed  PubMed Central  Google Scholar 

  52. The DCCT Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998;41(4):416-23.

  53. ••Pop-Busui R, Hotaling J, Braffett BH, Cleary PA, Dunn RL, Martin CL, et al. Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC. J Urol. 2015;193(6):2045–51. This article is the most recent examination of CAN and urologential complications in men with diabetes.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553–79.

    Article  PubMed  Google Scholar 

  55. Low PA, Benrud-Larson LM, Sletten DM, Opfer-Gehrking TL, Weigand SD, O’Brien PC, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27(12):2942–7.

    Article  PubMed  Google Scholar 

  56. ••Hotaling JM, Sarma AV, Patel DP, Braffett BH, Cleary PA, Feldman E, et al. Cardiovascular autonomic neuropathy, sexual dysfunction, and urinary incontinence in women with type 1 diabetes. Diabetes Care. 2016;39(9):1587–93. This article is the most recent examination of CAN and urologential complications in women with diabetes.

    Article  PubMed  Google Scholar 

  57. Ghafoor A, Zaidi SMH, Moazzam A. Frequency of autonomic neuropathy in patients with erectile dysfunction in diabetes mellitus. J Ayub Med Coll Abbottabad. 2015;27(3):653–5.

    PubMed  Google Scholar 

  58. Hamdan FB, Al-Matubsi HY. Assessment of erectile dysfunction in diabetic patients. Int J Androl. 2009;32(2):176–85.

    Article  PubMed  Google Scholar 

  59. Debono M, Cachia E, Cassar A, Calleja N, Mallia M, Vassallo J. Is erectile dysfunction a sentinel symptom for cardiovascular autonomic neuropathy in patients with type 2 diabetes? Andrologia. 2008;40(1):1–6.

    Article  CAS  PubMed  Google Scholar 

  60. Pegge NC, Twomey AM, Vaughton K, Gravenor MB, Ramsey MW, Price DE. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment. Diabet Med. 2006;23(8):873–8.

    Article  CAS  PubMed  Google Scholar 

  61. Bleustein C, Arezzo JC, Eckholdt H, Melman A. The neuropathy of erectile dysfunction. Int J Impot Res. 2002;14(6):433–9.

    Article  CAS  PubMed  Google Scholar 

  62. De Angelis L, Marfella MA, Siniscalchi M, Marino L, Nappo F, Giugliano F, et al. Erectile and endothelial dysfunction in type II diabetes: a possible link. Diabetologia. 2001;44(9):1155–60.

    Article  PubMed  Google Scholar 

  63. Hecht MJ, Neundörfer B, Kiesewetter F, Hilz MJ. Neuropathy is a major contributing factor to diabetic erectile dysfunction. Neurol Res. 2013;23(6):651–4.

    Article  Google Scholar 

  64. Fedele D, Coscelli C, Cucinotta D, Forti G, Santeusanio F, Viaggi S, et al. Incidence of erectile dysfunction in Italian men with diabetes. J Urol. 2001;166(4):1368–71.

    Article  CAS  PubMed  Google Scholar 

  65. Wellmer A, Sharief M, Knowles C, Misra V, Kopelman P, Ralph D, et al. Quantitative sensory and autonomic testing in male diabetic patients with erectile dysfunction. BJU Int. 1999;83(1):66–70.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Biostatistics Center, George Washington University, 6110 Executive Blvd, Suite 750, Rockville, MD, 20852, USA

    Barbara H. Braffett

  2. Department of Urology, University of Washington School of Medicine, 1959 NE Pacific St, Box 356510, Seattle, WA, 98195, USA

    Hunter Wessells

  3. Department of Urology, University of Michigan, 2800 Plymouth Rd, Bldg 16, 109E, Ann Arbor, MI, 48109, USA

    Aruna V. Sarma

Authors
  1. Barbara H. Braffett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hunter Wessells
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aruna V. Sarma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara H. Braffett.

Ethics declarations

Conflict of Interest

Barbara H. Braffett, Hunter Wessells, and Aruna V. Sarma declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Microvascular Complications—Neuropathy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Braffett, B.H., Wessells, H. & Sarma, A.V. Urogenital Autonomic Dysfunction in Diabetes. Curr Diab Rep 16, 119 (2016). https://doi.org/10.1007/s11892-016-0824-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-016-0824-5

Keywords

Search

Navigation